Contraceptive Agents, Female
"Contraceptive Agents, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
|Contraceptive Agents, Female
- Contraceptive Agents, Female
- Agents, Female Contraceptive
- Female Contraceptive Agents
- Contraceptives, Female
- Female Contraceptives
Below are MeSH descriptors whose meaning is more general than "Contraceptive Agents, Female".
Below are MeSH descriptors whose meaning is more specific than "Contraceptive Agents, Female".
This graph shows the total number of publications written about "Contraceptive Agents, Female" by people in this website by year, and whether "Contraceptive Agents, Female" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Contraceptive Agents, Female" by people in Profiles.
Peterson JM, Krueger K, Stanback J. Indicators for Monitoring and Evaluation of Community-Based Injectable Contraception: Multisourced Process and New Global Guidance. Glob Health Sci Pract. 2019 09; 7(3):491-497.
Peterson AM, Brown A, Savage A, Dempsey A. Prevalence of early discontinuation and associated factors among a retrospective cohort of etonogestrel contraceptive implant users. Eur J Contracept Reprod Health Care. 2019 Dec; 24(6):475-479.
Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL, Steck SE. Progestin and breast cancer risk: a systematic review. Breast Cancer Res Treat. 2016 Jan; 155(1):3-12.
Dickerson LM, Diaz VA, Jordon J, Davis E, Chirina S, Goddard JA, Carr KB, Carek PJ. Satisfaction, early removal, and side effects associated with long-acting reversible contraception. Fam Med. 2013 Nov-Dec; 45(10):701-7.
Soper DE. The intrauterine device: a good thing revisited. Obstet Gynecol. 2013 May; 121(5):919-920.
Dempsey AR, Billingsley CC, Savage AH, Korte JE. Predictors of long-acting reversible contraception use among unmarried young adults. Am J Obstet Gynecol. 2012 Jun; 206(6):526.e1-5.
Dempsey A, Roca C, Westhoff C. Vaginal estrogen supplementation during Depo-Provera initiation: a randomized controlled trial. Contraception. 2010 Sep; 82(3):250-5.
Gordon L, Thakur N, Atlas M, Januchowski R. Clinical inquiries. What hormonal contraception is most effective for obese women? J Fam Pract. 2007 Jun; 56(6):471-3.
Thurman AR, Livengood CH, Soper DE. Chronic endometritis in DMPA users and Chlamydia trachomatis endometritis. Contraception. 2007 Jul; 76(1):49-52.
Thurman AR, Soper DE. Endometrial histology of Depomedroxyprogesterone acetate users: a pilot study. Infect Dis Obstet Gynecol. 2006; 2006:69402.